Skip to Content

GG 614 GG 614 (Ranitidine Hydrochloride 150 mg)

Pill with imprint GG 614 GG 614 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Ranitidine is used in the treatment of duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GG 614 GG 614

Ranitidine hydrochloride 150 mg GG 614 GG 614
Ranitidine hydrochloride 150 mg GG 614 GG 614 Front
Ranitidine hydrochloride 150 mg GG 614 GG 614 Back
Ranitidine hydrochloride 150 mg GG 614 GG 614

Ranitidine Hydrochloride

Imprint:
GG 614 GG 614
Strength:
150 mg
Color:
Brown
Size:
16.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-2855
Inactive Ingredients:

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide